NINTEDONE 150
Nintedanib (150mg)
Nintedanib, known by its brand name NINTEDONE 150, is a potent medication designed to treat idiopathic pulmonary fibrosis (IPF) and certain forms of non-small cell lung cancer (NSCLC). This drug works by inhibiting multiple pathways that contribute to disease progression.
Uses
Nintedanib is utilized in the treatment of idiopathic pulmonary fibrosis, a debilitating lung disease that causes progressive scarring of lung tissue. It is also prescribed for advanced non-small cell lung cancer with adenocarcinoma histology. By inhibiting tyrosine kinases, Nintedanib effectively slows the progression of these diseases, providing significant symptomatic relief and improved patient outcomes.
Dosage
For the management of IPF and NSCLC, the standard dosage of NINTEDONE 150 is 150mg taken twice daily, with a gap of approximately 12 hours between doses. It is recommended to consume the capsules with food to minimize gastrointestinal discomfort and enhance drug absorption. Adhering to the prescribed dosage and schedule is crucial for the medication’s efficacy.
Side Effects
Patients taking Nintedanib may experience side effects such as diarrhea, nausea, vomiting, abdominal discomfort, and loss of appetite. Elevated liver enzymes are another common side effect, necessitating regular liver function tests. In rare cases, severe side effects like liver damage and gastrointestinal perforation may occur, requiring immediate medical intervention.
Price
In India, the cost of NINTEDONE 150 generally falls between ₹45,000 and ₹55,000 per month. Prices can vary based on the pharmacy and specific regional pricing policies, so it is advisable to compare prices and seek possible discounts.
More Information
Patients need to discuss their full medical history with their healthcare provider before starting Nintedanib to ensure its appropriateness and to avoid potential drug interactions. Continuous monitoring through follow-up visits is important to manage any side effects and to evaluate the treatment\'s effectiveness. Nintedanib provides a significant therapeutic benefit for patients with IPF and NSCLC, offering hope by managing disease progression and improving life quality. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. Based in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, underscoring its commitment to quality and safety. Sterispharma is dedicated to providing high-quality drugs at affordable prices across India, strictly adhering to WHO guidelines. Sterispharma offers the convenience of an online pharmacy, enabling customers to easily purchase medicines and benefit from home delivery. The company\'s mission is to supply a wide array of healthcare products to meet the diverse needs of the medical community. Whether it\'s advanced treatments, medications for rare conditions, or essential health necessities, Sterispharma strives to serve the broad demands of the healthcare industry. If you need medicine then you can order it on these two websites sterisonline and sterispharma Order Now Sterispharma\'s extensive product lineup includes treatments for various health areas such as Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.
For further information:
Email: info@sterispharma.com / contact@sterispharma.com
Call/WhatsApp: 7877551268, 7849827488
